MedTrace Logo

Effects of Metformin on Low Back Pain

NCT04055012 · Status: TERMINATED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 23

Last updated 2025-02-21

Study results available
· View outcomes & findings →

Summary

The purpose of the current study is to determine the effects of metformin in non-diabetic patients with low back pain, and identify novel targets for future treatments

Conditions

  • Low Back Pain

Interventions

DRUG

Metformin

500mg tabs of Metformin Extended Release

DRUG

Placebo

Placebo Tabs

Sponsors & Collaborators

  • Gwendolyn Sowa

    lead OTHER

Principal Investigators

  • Gwendolyn Sowa, MD, PhD · The University of Pittsburgh

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-01-07
Primary Completion
2023-12-15
Completion
2023-12-15
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04055012 on ClinicalTrials.gov